Search Orphan Drug Designations and Approvals
-
Generic Name: | 1,5-(Butylimino)-1,5 dideoxy,D-glucitol |
---|---|
Date Designated: | 05/12/1998 |
Orphan Designation: | Treatment of Fabry's disease. |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Oxford GlycoSciences 10, The Quadrant Abington Science Park Abington, Oxfordshire United Kingdom The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-